Bayer Hits Abbott With Patent Suit Over Humira
In a complaint filed Wednesday in the U.S. District Court for the Eastern District of Texas, Bayer accused Abbott of infringing U.S. Patent Number 5,654,407, titled “Human anti-TNF antibodies,” by selling Humira in the U.S.
The '407 patent, issued in 1997, describes an antibody that binds to human tumor necrosis factor alpha, a compound involved in inflammatory diseases.
Humira, which was approved by the U.S. Food and...
To view the full article, register now.